Your browser doesn't support javascript.
loading
Monocyte subsets associated with the efficacy of anti­PD­1 antibody monotherapy.
Ohkuma, Ryotaro; Fujimoto, Yuki; Ieguchi, Katsuaki; Onishi, Nobuyuki; Watanabe, Makoto; Takayanagi, Daisuke; Goshima, Tsubasa; Horiike, Atsushi; Hamada, Kazuyuki; Ariizumi, Hirotsugu; Hirasawa, Yuya; Ishiguro, Tomoyuki; Suzuki, Risako; Iriguchi, Nana; Tsurui, Toshiaki; Sasaki, Yosuke; Homma, Mayumi; Yamochi, Toshiko; Yoshimura, Kiyoshi; Tsuji, Mayumi; Kiuchi, Yuji; Kobayashi, Shinichi; Tsunoda, Takuya; Wada, Satoshi.
Afiliação
  • Ohkuma R; Division of Medical Oncology, Department of Medicine, School of Medicine, Showa University, Tokyo 142-8555, Japan.
  • Fujimoto Y; Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo 157-8577, Japan.
  • Ieguchi K; Division of Medical Oncology, Department of Medicine, School of Medicine, Showa University, Tokyo 142-8555, Japan.
  • Onishi N; Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo 157-8577, Japan.
  • Watanabe M; Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo 157-8577, Japan.
  • Takayanagi D; Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo 157-8577, Japan.
  • Goshima T; Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo 157-8577, Japan.
  • Horiike A; Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo 157-8577, Japan.
  • Hamada K; Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo 157-8577, Japan.
  • Ariizumi H; Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo 157-8577, Japan.
  • Hirasawa Y; Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo 157-8577, Japan.
  • Ishiguro T; Division of Medical Pharmacology, Department of Pharmacology, School of Medicine, Showa University, Tokyo 142-8555, Japan.
  • Suzuki R; Pharmacological Research Center, Showa University, Tokyo 142-8555, Japan.
  • Iriguchi N; Division of Medical Oncology, Department of Medicine, School of Medicine, Showa University, Tokyo 142-8555, Japan.
  • Tsurui T; Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo 157-8577, Japan.
  • Sasaki Y; Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo 157-8577, Japan.
  • Homma M; Division of Medical Oncology, Department of Medicine, School of Medicine, Showa University, Tokyo 142-8555, Japan.
  • Yamochi T; Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo 157-8577, Japan.
  • Yoshimura K; Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo 157-8577, Japan.
  • Tsuji M; Division of Medical Oncology, Department of Medicine, School of Medicine, Showa University, Tokyo 142-8555, Japan.
  • Kiuchi Y; Division of Medical Oncology, Department of Medicine, School of Medicine, Showa University, Tokyo 142-8555, Japan.
  • Kobayashi S; Division of Medical Oncology, Department of Medicine, School of Medicine, Showa University, Tokyo 142-8555, Japan.
  • Tsunoda T; Division of Medical Oncology, Department of Medicine, School of Medicine, Showa University, Tokyo 142-8555, Japan.
  • Wada S; Division of Medical Oncology, Department of Medicine, School of Medicine, Showa University, Tokyo 142-8555, Japan.
Oncol Lett ; 26(3): 381, 2023 Sep.
Article em En | MEDLINE | ID: mdl-37559573

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article